Hemoglobin A1c and Early Gestational Diabetes

Ashley N Battarbee1, Jacqueline H Grant1, Catherine J Vladutiu1

  • 1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Insights

Hemoglobin A1c (HbA1c) shows moderate predictive power for early gestational diabetes mellitus (GDM) diagnosis in high-risk pregnancies. A lower HbA1c threshold than in nonpregnant adults may be suitable for early GDM screening.

Area of Science:

  • Obstetrics and Gynecology
  • Endocrinology
  • Clinical Diagnostics

Background:

  • Early screening for gestational diabetes mellitus (GDM) is recommended for high-risk pregnancies.
  • The optimal diagnostic test for early GDM remains undetermined.
  • Evaluating alternative diagnostic markers is crucial for timely GDM management.

Purpose of the Study:

  • To assess the diagnostic accuracy of hemoglobin A1c (HbA1c) for early GDM detection.
  • To compare HbA1c performance against the established two-step diagnostic approach.
  • To determine an optimal HbA1c threshold for identifying early GDM.

Main Methods:

  • Retrospective cohort study of 243 women with prior GDM or obesity.
  • HbA1c and two-step GDM testing performed before 21 weeks' gestation.
  • Receiver operating characteristic curve analysis to evaluate HbA1c diagnostic performance.

Main Results:

  • 14 women (5.8%) were diagnosed with early GDM.
  • Median HbA1c levels were significantly higher in women with GDM (5.8%) versus those without (5.3%).
  • HbA1c demonstrated a moderate area under the curve (AUC) of 0.80 for early GDM diagnosis, with an optimal threshold of 5.6% (64% sensitivity, 84% specificity).

Conclusions:

  • Hemoglobin A1c is a moderately predictive marker for early gestational diabetes mellitus.
  • The findings support the use of HbA1c as a potential screening tool for early GDM in high-risk pregnancies.
  • A diagnostic threshold for HbA1c lower than that used for nonpregnant adults is warranted for early GDM detection.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
679
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.0K